Similar Papers

Paper Title
Journal
Date
Author
Atogepant for the preventive treatment of chronic migraine: results from the PROGRESS phase 3 trial (S47.005)
Patricia Pozo-Rosich ... Emily Mccusker
Neurology | VOL. 100
Patricia Pozo-Rosich, et. al.Patricia Pozo-Rosich ... Emily Mccusker
25 Apr 2023
Safety and Tolerability of Rimegepant Every Other Day for Preventive Treatment of Migraine Plus As-Needed for Acute Treatment of Migraine: Results from A 52-Week, Open-Label Extension Phase (P12-12.006)
Richard Lipton ... Christopher Jensen
Neurology | VOL. 100
Richard Lipton, et. al.Richard Lipton ... Christopher Jensen
25 Apr 2023
Responder Rates With Eptinezumab Over 24 Weeks in Patients With Prior Migraine Preventive Treatment Failures (S47.007)
Messoud Ashina ... Jessica Ailani
Neurology | VOL. 100
Messoud Ashina, et. al.Messoud Ashina ... Jessica Ailani
25 Apr 2023
Consistency of Response to Liquid Celecoxib in Adults With Migraine: Post Hoc Analysis of Results From Two Randomized, Placebo-Controlled Studies (P13-12.005)
Daniel Serrano ... Richard Lipton
Neurology | VOL. 100
Daniel Serrano, et. al.Daniel Serrano ... Richard Lipton
25 Apr 2023
View more papers

More From: Neurology

Paper Title
Journal
Date
Author
Teaching NeuroImage: Vessel Wall Imaging of a Vertebral Artery Web.
Jiashu Li ... Xingquan Zhao
Neurology | VOL. 104
Jiashu Li, et. al.Jiashu Li ... Xingquan Zhao
14 Jan 2025
Teaching NeuroImage: Wallerian Degeneration of the Corticospinal Tract After Cerebral Hemorrhage.
Kunyi Li ... Lan Wen
Neurology | VOL. 104
Kunyi Li, et. al.Kunyi Li ... Lan Wen
14 Jan 2025
Antibiotic Use and Subsequent Cognitive Decline and Dementia Risk in Healthy Older Adults.
Yiqing Wang ... Andrew T Chan
Neurology | VOL. 104
Yiqing Wang, et. al.Yiqing Wang ... Andrew T Chan
14 Jan 2025
More Questions Than Answers About Poststroke Cognitive Impairment and Dementia.
Deborah A Levine
Neurology | VOL. 104
Deborah A LevineDeborah A Levine
14 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.